Results 51 to 60 of about 51,514 (235)

Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth.

Cutis (New York, N.Y.), 2023
Alopecia universalis is alopecia areata (AA) with total-body involvement of hair loss. The disease progression is due to autoimmune T cells. We present a case of a patient with alopecia universalis who was successfully treated with tofacitinib.
Lauren Schwartzberg, Amy Spizuoco
semanticscholar   +1 more source

A mixed methods survey of social anxiety, anxiety, depression and wig use in alopecia [PDF]

, 2017
Objectives This study aimed to examine levels of social anxiety, anxiety and depression reported by people with alopecia as a result of a dermatological condition and associations with wig use.
Bewley, Cash, Cash, Cash, Chiang, Clarke, Connor, Goffman, Hunt, Hunt, Kacar, Koo, Kroenke, Kroenke, Lavda, Macbeth, Mayring, Messenger, Rosman, Ruiz-Doblado, Rumsey, Smart Richman, Spitzer, Spitzer, SPSS: IBM Corp, Thompson, Thompson, Tucker, Welsh, Wiggins   +29 more
core   +1 more source

Genetic Pigmentary Disorders: From Molecular Mechanisms to Clinical Manifestations

The Journal of Dermatology, EarlyView.
ABSTRACT Genetic pigmentary disorders represent a diverse group of genetic conditions characterized by alterations in melanin production and transport and melanocyte development, resulting from single‐gene pathological variants. These disorders encompass both hypopigmentary and hyperpigmentary phenotypes, affecting not only skin pigmentation but also ...
Ken Okamura, Tamio Suzuki
wiley   +1 more source

Alopecia Universalis Treated with Ayurveda Protocol and Assessed by SALT (Severity of Alopecia Tool) - A Case Report

Journal of Natural Remedies, 2023
Alopecia Universalis is a condition that causes generalized hair loss in the body. It is associated with nail changes in 10-15 % of Autoimmune origin conditions.
V. Archana, Delvin T. Robin, Preeti Mohan, James Chacko   +3 more
semanticscholar   +1 more source

Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO‐2b/3

International Journal of Dermatology, EarlyView.
ABSTRACT Background Patients with alopecia areata (AA) in ALLEGRO‐2b/3 (NCT03732807) had clinically significant hair regrowth and patient‐reported improvements with ritlecitinib versus placebo, but patient‐reported improvements in AA Patient Priority Outcomes (AAPPO) emotional symptoms (ES) or activity limitations (AL) were not observed during the 24 ...
Ernest H. Law, Bintu Sherif, Arash Mostaghimi, Brett King, Rodney Sinclair, Natasha Mesinkovska, Kent A. Hanson, Dane Korver, Costel Chirila   +8 more
wiley   +1 more source

Comparison of oral prednisolone pulse therapy with intravenous methylprednisolone pulse therapy in severe alopecia areata [PDF]

, 2013
Objective: To compare the efficacy of oral prednisolone pulse therapy in comparison to the intravenous methylprednisolone pulse therapy in treatment of severe alopecia areata. Patients and methods: In this interventional study, all patients with alopecia
Alborzi, A., Dehghan, A., Shahini, N.
core  

New Modalities in the Treatment of Refractory Alopecia Areata [PDF]

, 2017
Alopecia areata (AA) is a common and complex T-cell–mediated inflammatory disorder. It may be patchy (localized), involve the entire scalp (alopecia totalis) or entire body (alopecia universalis).
Kılıç, Arzu
core   +2 more sources

Experience with oral tofacitinib in severe alopecia areata with different clinical responses [PDF]

, 2021
Background: Alopecia areata (AA) and generalized form, universalis (AU) are common causes of noncicatricial alopecia, targeting anagen hair follicles. A dominant interferon-gamma transcriptional signaling and cytotoxic T lymphocytes were accused as ...
Dinçer Rota, Didem, Emeksiz, Mehmet Ali Can, Erdoğan, Fatma Gülru, Yıldırım, Dilsun   +3 more
core   +1 more source

A man with hypophosphataemia [PDF]

, 2011
Case report; A section on BMJ, 2011, v.
Kung, AW, Lam, CW, Lam, JK, Lam, KS, Lau, KS, Tan, KC   +5 more
core   +1 more source

Clinical heterogeneity in vitiligo: Identification of clinical markers based patient clusters

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Vitiligo is a chronic autoimmune disease with heterogeneous clinical presentations. This study analysed 399 patients using hierarchical clustering and identified five phenotypes based on clinical characteristics and lesion distribution. Two groups exhibited high disease activity and extensive involvement.
Laura Galissi, Tristan Benoît, Ribal Merhi, Claire Drullion, Nicolas Andreu, Khaled Ezzedine, Thomas Darde, Katia Boniface, Julien Seneschal   +8 more
wiley   +1 more source